哈药股份
(600664)
| 流通市值：130.21亿 | | | 总市值：130.21亿 |
| 流通股本：25.19亿 | | | 总股本：25.19亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 12,352,336,835.28 | 8,295,656,520.47 | 4,175,172,325.87 | 15,964,064,818.53 |
| 营业总成本 | 11,588,449,403.71 | 7,791,338,229.06 | 3,962,817,877.77 | 15,347,569,067.04 |
| 其他经营收益 | | | | |
| 营业利润 | 785,224,164.82 | 521,002,632.66 | 208,137,427.93 | 586,026,743.33 |
| 利润总额 | 781,697,976.17 | 517,858,470.2 | 206,432,431.56 | 572,738,622.08 |
| 净利润 | 619,242,509.53 | 409,075,631.91 | 161,071,923.96 | 398,777,512.49 |
| 每股收益 | | | | |
| 其他综合收益 | 308,261.09 | 516,936.15 | 33,249.11 | -2,503,704.81 |
| 综合收益总额 | 619,550,770.62 | 409,592,568.06 | 161,105,173.07 | 396,273,807.68 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 11,325,563,900.66 | 11,054,993,529.94 | 11,037,959,035.16 | 10,653,020,066.08 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,577,343,926.16 | 3,580,472,215.04 | 3,614,581,728.17 | 3,634,639,324.79 |
| 资产总计 | 14,902,907,826.82 | 14,635,465,744.98 | 14,652,540,763.33 | 14,287,659,390.87 |
| 流动负债: | | | | |
| 流动负债合计 | 7,396,194,986.05 | 7,333,599,210.96 | 7,610,502,914.98 | 7,422,587,268.83 |
| 非流动负债: | | | | |
| 非流动负债合计 | 412,165,962.7 | 417,277,858.51 | 405,936,567.83 | 402,976,930.48 |
| 负债合计 | 7,808,360,948.75 | 7,750,877,069.47 | 8,016,439,482.81 | 7,825,564,199.31 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,295,572,721.8 | 6,105,875,251.15 | 5,860,019,884.88 | 5,688,095,822.23 |
| 股东权益合计 | 7,094,546,878.07 | 6,884,588,675.51 | 6,636,101,280.52 | 6,462,095,191.56 |
| 负债和股东权益合计 | 14,902,907,826.82 | 14,635,465,744.98 | 14,652,540,763.33 | 14,287,659,390.87 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 12,817,946,719.72 | 8,476,798,405.22 | 3,891,995,694 | 16,848,265,358.73 |
| 经营活动现金流出小计 | 12,691,940,670.8 | 8,523,065,187.13 | 4,078,055,943.97 | 16,408,609,315.61 |
| 经营活动产生的现金流量净额 | 126,006,048.92 | -46,266,781.91 | -186,060,249.97 | 439,656,043.12 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 63,402,081.57 | 62,874,888.06 | 27,490 | 7,858,969.58 |
| 投资活动现金流出小计 | 98,535,727.29 | 63,801,176.9 | 21,172,024.46 | 150,946,595.5 |
| 投资活动产生的现金流量净额 | -35,133,645.72 | -926,288.84 | -21,144,534.46 | -143,087,625.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 899,805,043.49 | 737,079,588.75 | 345,331,018.06 | 1,346,546,616.46 |
| 筹资活动现金流出小计 | 1,132,106,482.57 | 704,254,091.33 | 369,878,333.95 | 1,803,736,343.11 |
| 筹资活动产生的现金流量净额 | -232,301,439.08 | 32,825,497.42 | -24,547,315.89 | -457,189,726.65 |
| 汇率变动对现金及现金等价物的影响 | -3,308,636.79 | -2,660,398.4 | -1,708,743.27 | -2,691,109.82 |
| 现金及现金等价物净增加额 | -144,737,672.67 | -17,027,971.73 | -233,460,843.59 | -163,312,419.27 |
| 期末现金及现金等价物余额 | 3,218,307,596.73 | 3,346,017,297.67 | 3,129,584,425.81 | 3,363,045,269.4 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -17,027,971.73 | - | -163,312,419.27 |
最新报告期：2026-08-26| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 代雯,唐庆雷,张云逸 | 0.24 | 0.28 | 0.32 | 2026-08-26 |